Latest SYRS reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Syros Pharmaceuticals
  4. Financial Ratios
  5. EV/EBITDA Ratio
Syros Pharmaceuticals logo
Syros Pharmaceuticals SYRS
$ 5.1 2.0%
mail-toReport an Error

Syros Pharmaceuticals EV/EBITDA Ratio 2011-2024 | SYRS

Annual EV/EBITDA Ratio Syros Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.308 -4.63 -3.21 -2.16 -4.39 -1.65 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.308 -4.63 -2.62